|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts and note receivable-net | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable-net | ||||||||||||||||||||
| Note receivable-net | ||||||||||||||||||||
| Inventories-net | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Deferred other costs-current | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Note receivable-non-current | ||||||||||||||||||||
| Property, plant and equipment-net | ||||||||||||||||||||
| Right of use assets-operating leases | ||||||||||||||||||||
| Right of use assets-finance leases-net | ||||||||||||||||||||
| Intangible assets, net (excluding goodwill) | ||||||||||||||||||||
| Customer relationships | ||||||||||||||||||||
| Brands | ||||||||||||||||||||
| Total intangible assets, net (excluding goodwill) | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deferred other costs-non-current | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Accrued distributor termination fees | ||||||||||||||||||||
| Accrued promotional allowance | ||||||||||||||||||||
| Lease liability operating leases | ||||||||||||||||||||
| Lease liability finance leases | ||||||||||||||||||||
| Contingent consideration | ||||||||||||||||||||
| Deferred revenue-current | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Lease liability operating leases | ||||||||||||||||||||
| Lease liability finance leases | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Deferred revenue-non-current | ||||||||||||||||||||
| Other long term liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Mezzanine equity, shares outstanding (in shares) | ||||||||||||||||||||
| Series A Convertible Preferred Stock | ||||||||||||||||||||
| Series B Convertible Preferred Stock | ||||||||||||||||||||
| Total mezzanine equity, shares outstanding (in shares) | ||||||||||||||||||||
| Mezzanine equity, shares issued (in shares) | ||||||||||||||||||||
| Series A Convertible Preferred Stock | ||||||||||||||||||||
| Series B Convertible Preferred Stock | ||||||||||||||||||||
| Mezzanine equity, par value (in USD per share) | ||||||||||||||||||||
| Series A convertible preferred stock, $0.001 par value per share, 1,467 shares issued and outstanding as of both June 30, 2026 and December 31, 2025 and Series B convertible preferred stock, $0.001 par value per share, 390 shares issued and outstanding as of both June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Series A Convertible Preferred Stock | ||||||||||||||||||||
| Series B Convertible Preferred Stock | ||||||||||||||||||||
| Total series A convertible preferred stock, $0.001 par value per share, 1,467 shares issued and outstanding as of both June 30, 2026 and December 31, 2025 and Series B convertible preferred stock, $0.001 par value per share, 390 shares issued and outstanding as of both June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common Stock, $0.001 par value per share; 400,000 shares authorized; 258,703 shares issued and 253,341 shares outstanding as of June 30, 2026; and 258,108 shares issued and 256,906 shares outstanding as of December 31, 2025 | ||||||||||||||||||||
| Treasury stock, at cost; 5,362 shares and 1,202 shares as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| Total Liabilities, Mezzanine Equity and Stockholders’ Equity | ||||||||||||||||||||
Loading...